Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
Keyword(s):
2012 ◽
Vol 26
(6)
◽
pp. 691-703
◽
2013 ◽
Vol 66
(8)
◽
pp. 700-704
◽
2012 ◽
Vol 26
(6)
◽
pp. 843-854
◽